SciELO - Scientific Electronic Library Online

 
vol.31 número6Utilidad del ecocardiograma bidimensional en el diagnóstico de la estenosis coronaria grave en pacientes con síndrome coronario agudo sin elevación del segmento STHallazgos ecocardiográficos en pacientes hospitalizados por COVID-19 y su relación con la mortalidad intrahospitalaria y al año del alta índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Cardiología

versión impresa ISSN 0120-5633

Resumen

CEBALLOS, Mateo; ARIAS, Sara  y  GAMBOA, Carlos. Health and economic impact of LDL cholesterol control in patients with atherosclerotic cardiovascular disease and high or very high cardiovascular risk: a simulation study for the Colombian context. Rev. Colomb. Cardiol. [online]. 2024, vol.31, n.6, pp.351-359.  Epub 10-Ene-2025. ISSN 0120-5633.  https://doi.org/10.24875/rccar.24000043.

Introduction:

Low-density lipoprotein cholesterol (LDL-c) is one of the modifiable risk factors with the greatest impact for atherosclerotic cardiovascular disease (ASCVD).

Objective:

To quantify the economic impact of LDL-c control in patients with ASCVD and high and very high cardiovascular risk in Colombia.

Method:

A Markov model was built from the perspective of the Colombian health-care system, to simulate the impact of a 50% reduction of LDL-c in the occurrence of major adverse cardiovascular events and direct avoided costs, over a time horizon of 5 and 10 years. The number of prevalent and incident patients and cost was quantified from public databases and local literature.

Results:

A 50% reduction in LDL-c over 5 years would prevent 105,826 events and reduce cost for the Colombian health-care system in COP $3.4 billion, a 36% decrease vs. no LDL-c control, while over 10 years these values rise to 199,583 events and COP $6 billion, a 34% reduction.

Conclusions:

In patients with ASCVD and high and very high cardiovascular risk, a sustained and consistent control of LDL-C prevents major adverse cardiovascular events and generates savings for the Colombian health-care system.

Palabras clave : LDL cholesterol; Atherosclerotic cardiovascular disease; Costs and cost analysis; Colombia.

        · resumen en Español     · texto en Español     · Español ( pdf )